How do we achieve adequate therapy for severe infection?

Critical Care Medicine

Volumn 31, Issue 2, 2003, Pages 648-650

  Karam, George H ^a   Niederman, Michael S ^b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

Adequate therapy; Antibiotic resistance; De escalation therapy; Guidelines; Pneumonia; Sepsis

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFTAZIDIME; CIPROFLOXACIN; IMIPENEM; OFLOXACIN; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ASSISTED VENTILATION; DISEASE PREDISPOSITION; DRUG DOSE REGIMEN; DRUG MIXTURE; EDITORIAL; ENTEROCOCCUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITALIZATION; INFECTION; KLEBSIELLA PNEUMONIAE; MORTALITY; OUTCOMES RESEARCH; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEPTIC SHOCK; SURVIVAL;

DRUG RESISTANCE, MICROBIAL; HUMANS; INFECTION; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC;

EID: 0037326738     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000050283.70684.EA     Document Type: Editorial

References (18)

1. Kollef MH, Sherman G, Ward S, et al: Inadequate antimicrobial treatment of infections: A risk factor for hospital mortality among critically ill patients. Chest 1999; 115:462-474
2. Ibrahim EH, Sherman G, Ward S, et al: The influence of inadequate antimicrobial treatment of bloodstream infection on patient outcomes in the ICU setting. Chest 2000; 118:146-155
3. Iregui M, Ward S, Sherman G, et al: Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002; 122:262-268
4. Luna CM, Vujacich P, Niederman MS, et al: Impact of BAL data on the therapy and outcome of ventilator associated pneumonia. Chest 1997; 111:676-685
5. Ibrahim EH, Ward S, Sherman G, et al: Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 2001; 29:1109-1115
6. Hoffken G, Niederman MS: Nosocomial pneumonia: The importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU. Chest 2002; 122:2183-2196
7. Leone M, Bourgoin A, Cambon S, et al: Empirical antimicrobial therapy of septic shock patients: Adequacy and impact on the outcome. Crit Care Med 2003; 31:462-467
8. Fridkin SK, Steward CD, Edwards JR, et al: Surveillance of antimicrobial use and anti-microbial resistance in United States hospitals: Project ICARE Phase 2. Clin Infect Dis 1999; 29:245-252
9. Rahal JJ, Urban C, Horn D, et al: Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 1998; 280:1233-1237
10. Burke JP: Antibiotic resistance: Squeezing the balloon? JAMA 1998; 280:1270-1271
11. Rahal JJ, Urban C, Segal-Maurer: Nosocomial antibiotic resistance in multiple gram-negative species: Experience at one hospital with squeezing the resistance balloon at multiple sites. Clin Infect Dis 2002; 34:499-503
12. Landman D, Quale JM, Mayorga D, et al: Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, N-Y: The preantibiotic era has returned. Arch Intern Med 2002; 162:1515-1520
13. Livermore DM: Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: Our worst nightmare? Clin Infect Dis 2002; 34:634-640
14. Trouillet JL, Vuagnat A, Combes A, et al: Pseudomonas aeruginosa ventilator-associated pneumonia: Comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms. Clin Infect Dis 2002; 34:1047-1054
15. Hanes SD, Demirkan K, Tolley E, et al: Risk factors for late-onset nosocomial pneumonia caused by Stenotrophomonas maltophilia in critically ill trauma patients. Clin Infect Dis 2002; 35:228-235
16. Fridkin SK, Edwards JR, Courval JM, et al: The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 US Adult Intensive Care Units: The Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Project and the National Nosocomial Infections Surveillance (NNIS) System Hospitals. Ann Intern Med 2001; 135:175-183
17. Carmeli Y, Eliopoulos GM, Samore MH: Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus. Emerg Infect Dis 2002; 8:802-807
18. Burke JP, Pestotnik SL: Computer-assisted prescribing and its impact on resistance. In: Antibiotic Therapy and Control of Antimicrobial Resistance in Hospitals. Andremont A, Brun-Buisson C, McGowan JE (Eds). Elsevier, Paris, 1999, pp 89-95